ResMed (RMD) Misses Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $253.06 +2.79%
Revenue Growth %: +6.9%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
ORPB, PBCO, SICP, More
Revenue Growth %: +6.9%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
ORPB, PBCO, SICP, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.58, $0.01 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $411.6 million versus the consensus estimate of $406.29 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- First Western Financial, Inc. (MYFW) Reports In-Line Q3 EPS
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
